Cabergoline Medication Guide: How to Take it Safely and Effectively

Cabergoline (Cabergoline) is a drug used to treat hyperprolactinemia. It is suitable for patients with abnormally elevated prolactin levels in the body due to various reasons. High prolactin levels can lead to a range of health problems, including bone loss, irregular menstruation, infertility, unwanted milk production, and sexual dysfunction. Through the rational use of cabergoline, patients can effectively control prolactin levels, thereby improving related symptoms and improving quality of life.

Concerning how cabergoline is administered, treatment usually starts with a lower dose. The recommended initial dose is 0.25 mg twice weekly. On this basis, the doctor will gradually adjust the dosage according to the patient's serum prolactin level. Specifically, the dose may be increased by 0.25 mg weekly until a maximum dose of 1 mg twice weekly is reached. This process requires patients to perform it under the supervision of a physician so that adjustments can be made based on individual responses. Also, before starting treatment, patients are advised to undergo a cardiovascular evaluation and may need an echocardiogram to ensure there is no risk of valvular heart disease.

During the dose adjustment process, it is important to note that dose increases should not occur more frequently than every four weeks. This is to allow doctors to fully assess the patient's response to each dose. If a patient is found to be failing to achieve significant results at higher doses, doctors will often choose to use the lowest dose that achieves the best response and may consider other treatment options. In addition, patients taking long-term cabergoline should have regular heart health evaluations and, if necessary, echocardiography to monitor for potential cardiovascular complications.

When the patient's serum prolactin levels remain within the normal range for six months, discontinuation of cabergoline may be considered. However, to ensure the stability of prolactin levels, doctors will recommend regular monitoring of serum prolactin levels to determine whether treatment needs to be restarted. It should be noted that the long-term therapeutic effect of cabergoline has not been fully verified in patients for more than 24 months, so long-term use should be treated with caution.

Reference materials:https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a246b015-e19c-4b4f-9089-aea1108687ba